MAHRIKY Trademark

Trademark Overview

On Wednesday, June 9, 2021, a trademark application was filed for MAHRIKY with the United States Patent and Trademark Office. The USPTO has given the MAHRIKY trademark a serial number of 79316349. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by Novartis AG. The MAHRIKY trademark is filed in the Pharmaceutical Products category with the following description:

Prescription pharmaceutical preparations for medical purposes available only by prescription, all of the aforementioned goods limited for use in oncology and for the treatment of blood disorders and diseases and such goods specifically exclude skin care, cosmetics, vitamins, nutritional supplements, and any other pharmaceutical preparations for the treatment of non-cancerous skin conditions or diseases; biological preparations for medical purposes available only by prescription, all of the aforementioned goods limited for use in oncology and for the treatment of blood disorders and diseases and such goods specifically exclude skin care, cosmetics, vitamins, nutritional supplements, and any other pharmaceutical preparations for the treatment of non-cancerous skin conditions and diseases
mahriky

General Information

Serial Number79316349
Word MarkMAHRIKY
Filing DateWednesday, June 9, 2021
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6756411
Registration DateTuesday, June 14, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2022

Trademark Statements

Goods and ServicesPrescription pharmaceutical preparations for medical purposes available only by prescription, all of the aforementioned goods limited for use in oncology and for the treatment of blood disorders and diseases and such goods specifically exclude skin care, cosmetics, vitamins, nutritional supplements, and any other pharmaceutical preparations for the treatment of non-cancerous skin conditions or diseases; biological preparations for medical purposes available only by prescription, all of the aforementioned goods limited for use in oncology and for the treatment of blood disorders and diseases and such goods specifically exclude skin care, cosmetics, vitamins, nutritional supplements, and any other pharmaceutical preparations for the treatment of non-cancerous skin conditions and diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Tuesday, September 27, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, September 27, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 14, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Monday, April 4, 2022NOTIFICATION PROCESSED BY IB
Tuesday, March 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 9, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 17, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, February 17, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 17, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, February 17, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, January 22, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 5, 2021REFUSAL PROCESSED BY IB
Monday, November 8, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 8, 2021REFUSAL PROCESSED BY MPU
Wednesday, October 13, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 12, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 28, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 17, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, August 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 10, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 22, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

mahriky treatment goods skin diseases preparations pharmaceutical prescription care cosmetics nutritional